VVUS - バイバス (VIVUS Inc.)

VVUSのニュース

   Bankrupt Drugmaker Vivus Gets Approval to Preserve Tax Breaks  2020/07/08 19:42:00 The Wall Street Journal
Vivus, which filed for bankruptcy with plans to be acquired by Carl Icahn’s investment firm, received interim court approval to preserve $648 million in net operating losses that could be used to reduce future taxes.
   The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy  2020/07/08 11:31:40 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) AbbVie Inc (NYSE: ABBV ) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) argenx SE – ADR (NASDAQ: ARGX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (FDA approved the cellulitis drug it had licensed to Endo International PLC (NASDAQ: ENDP )) Cerus Corporation (NASDAQ: CERS ) (announced study results demonstrating that its INTERCEPT Blood System inactivates SARS-CoV-2 in plasma components intended for transfusion) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) ( announced initiation of a Phase 1 study of a potential coronavirus treatment) Crispr Therapeutics AG (NASDAQ: CRSP ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Immunomedics, Inc.
   VIVUS Reports First Quarter 2020 Financial Results  2020/05/06 20:05:00 GlobeNewswire
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a…
   VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt  2020/05/01 12:35:00 GlobeNewswire
CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced an agreement…
   Vivus Shares Rally On Accelerated Telemedicine Launch  2020/03/31 15:23:02 Benzinga
Shares of biopharma company VIVUS, Inc. (NASDAQ: VVUS ) are skyrocketing following an announcement concerning launch plans for telemedicine services. The Campbell, California-based company said it has accelerated the launch of telemedicine and remote monitoring modules for the Vivus Health Platform, which will allow participating physicians use it to conduct virtual office visits, regardless of whether the patient is prescribed a Vivus product. Vivus said it expects to enroll about 150-200 physicians in the new … Full story available on Benzinga.com
   Bankrupt Drugmaker Vivus Gets Approval to Preserve Tax Breaks  2020/07/08 19:42:00 The Wall Street Journal
Vivus, which filed for bankruptcy with plans to be acquired by Carl Icahn’s investment firm, received interim court approval to preserve $648 million in net operating losses that could be used to reduce future taxes.
   The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy  2020/07/08 11:31:40 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) AbbVie Inc (NYSE: ABBV ) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) argenx SE – ADR (NASDAQ: ARGX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (FDA approved the cellulitis drug it had licensed to Endo International PLC (NASDAQ: ENDP )) Cerus Corporation (NASDAQ: CERS ) (announced study results demonstrating that its INTERCEPT Blood System inactivates SARS-CoV-2 in plasma components intended for transfusion) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) ( announced initiation of a Phase 1 study of a potential coronavirus treatment) Crispr Therapeutics AG (NASDAQ: CRSP ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Immunomedics, Inc.
   VIVUS Reports First Quarter 2020 Financial Results  2020/05/06 20:05:00 GlobeNewswire
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a…
   VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt  2020/05/01 12:35:00 GlobeNewswire
CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced an agreement…
   Vivus Shares Rally On Accelerated Telemedicine Launch  2020/03/31 15:23:02 Benzinga
Shares of biopharma company VIVUS, Inc. (NASDAQ: VVUS ) are skyrocketing following an announcement concerning launch plans for telemedicine services. The Campbell, California-based company said it has accelerated the launch of telemedicine and remote monitoring modules for the Vivus Health Platform, which will allow participating physicians use it to conduct virtual office visits, regardless of whether the patient is prescribed a Vivus product. Vivus said it expects to enroll about 150-200 physicians in the new … Full story available on Benzinga.com
   Bankrupt Drugmaker Vivus Gets Approval to Preserve Tax Breaks  2020/07/08 19:42:00 The Wall Street Journal
Vivus, which filed for bankruptcy with plans to be acquired by Carl Icahn’s investment firm, received interim court approval to preserve $648 million in net operating losses that could be used to reduce future taxes.
   The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy  2020/07/08 11:31:40 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) AbbVie Inc (NYSE: ABBV ) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) argenx SE – ADR (NASDAQ: ARGX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) BioSpecifics Technologies Corp. (NASDAQ: BSTC ) (FDA approved the cellulitis drug it had licensed to Endo International PLC (NASDAQ: ENDP )) Cerus Corporation (NASDAQ: CERS ) (announced study results demonstrating that its INTERCEPT Blood System inactivates SARS-CoV-2 in plasma components intended for transfusion) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) ( announced initiation of a Phase 1 study of a potential coronavirus treatment) Crispr Therapeutics AG (NASDAQ: CRSP ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Immunomedics, Inc.
   VIVUS Reports First Quarter 2020 Financial Results  2020/05/06 20:05:00 GlobeNewswire
Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a…
   VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt  2020/05/01 12:35:00 GlobeNewswire
CAMPBELL, Calif., May 01, 2020 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced an agreement…
   Vivus Shares Rally On Accelerated Telemedicine Launch  2020/03/31 15:23:02 Benzinga
Shares of biopharma company VIVUS, Inc. (NASDAQ: VVUS ) are skyrocketing following an announcement concerning launch plans for telemedicine services. The Campbell, California-based company said it has accelerated the launch of telemedicine and remote monitoring modules for the Vivus Health Platform, which will allow participating physicians use it to conduct virtual office visits, regardless of whether the patient is prescribed a Vivus product. Vivus said it expects to enroll about 150-200 physicians in the new … Full story available on Benzinga.com

calendar